Cellectis (CLLS) EBT Margin Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -2,817.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1,558.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -683.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 2,688.00 |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | -32,180.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32,180.00 |
| Dec 31, 2025 | -57,409.00 |
| Sep 30, 2025 | 2,525.00 |
| Jun 30, 2025 | 6,745.00 |
| Mar 31, 2025 | 35,527.00 |
| Dec 31, 2024 | 3.08 Mn |
| Sep 30, 2024 | 914,347.00 |
| Jun 30, 2024 | -175,027.00 |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | -3.11 Mn |
| Sep 30, 2023 | 589,373.00 |
| Jun 30, 2023 | 370,363.00 |
| Mar 31, 2023 | -1.15 Mn |
| Dec 31, 2022 | 6,061.00 |
| Sep 30, 2022 | -1.45 Mn |
| Jun 30, 2022 | -162,500.00 |
| Mar 31, 2022 | -159,612.00 |
| Dec 31, 2021 | 20,827.00 |
| Sep 30, 2021 | -3,468.00 |
| Jun 30, 2021 | 80,363.00 |
| Mar 31, 2021 | -10,651.00 |
| Dec 31, 2020 | 58,340.00 |
| Sep 30, 2020 | -16,102.00 |
| Jun 30, 2020 | 191,013.00 |
| Mar 31, 2020 | 226,031.00 |
| Dec 31, 2019 | 215,291.00 |
| Sep 30, 2019 | 287,627.00 |
| Jun 30, 2019 | -261,942.00 |
| Mar 31, 2019 | -181,928.00 |
| Dec 31, 2018 | -262,148.00 |
| Sep 30, 2018 | -277,044.00 |
| Jun 30, 2018 | -12,426.00 |
| Mar 31, 2018 | -11,904.00 |
| Dec 31, 2017 | -15,389.00 |
| Sep 30, 2017 | -30,536.00 |
| Jun 30, 2017 | 137,261.00 |
| Mar 31, 2017 | -77.00 |
| Dec 31, 2016 | -25,153.00 |
| Sep 30, 2016 | 6,245.00 |
| Jun 30, 2016 | -151,258.00 |
| Mar 31, 2016 | -25,026.00 |